Company Quick10K Filing
Advanced Biomedical Technologies
10-Q 2021-04-30 Filed 2021-06-21
10-Q 2021-01-31 Filed 2021-03-22
10-K 2020-10-31 Filed 2021-01-29
10-Q 2020-07-31 Filed 2020-09-21
10-Q 2020-04-30 Filed 2020-06-22
10-Q 2020-01-31 Filed 2020-04-30
10-K 2019-10-31 Filed 2020-03-20
10-Q 2019-07-31 Filed 2019-09-20
10-Q 2019-04-30 Filed 2019-06-19
10-Q 2019-01-31 Filed 2019-04-01
10-K 2018-10-31 Filed 2019-02-13
10-Q 2018-07-31 Filed 2018-09-19
10-Q 2018-04-30 Filed 2018-06-19
10-Q 2018-01-31 Filed 2018-03-26
10-K 2017-10-31 Filed 2018-02-13
10-Q 2017-07-31 Filed 2017-09-19
10-Q 2017-04-30 Filed 2017-06-19
10-Q 2017-01-31 Filed 2017-03-22
10-K 2016-10-31 Filed 2017-02-14
10-Q 2016-07-31 Filed 2016-09-14
10-Q 2016-04-30 Filed 2016-06-20
10-Q 2016-01-31 Filed 2016-03-21
10-K 2015-10-31 Filed 2016-02-16
10-Q 2015-07-31 Filed 2015-09-21
10-Q 2015-04-30 Filed 2015-06-22
10-Q 2015-01-31 Filed 2015-03-23
10-K 2014-10-31 Filed 2015-01-29
10-Q 2014-07-31 Filed 2014-09-22
10-Q 2014-04-30 Filed 2014-06-23
10-Q 2014-01-31 Filed 2014-03-17
10-K 2013-10-31 Filed 2014-02-13
10-Q 2013-07-31 Filed 2013-09-16
10-Q 2013-04-30 Filed 2013-06-14
10-Q 2013-01-31 Filed 2013-03-25
10-K 2012-10-31 Filed 2013-02-13
10-Q 2012-07-31 Filed 2012-09-19
10-Q 2012-04-30 Filed 2012-06-19
10-Q 2012-01-31 Filed 2012-03-21
10-K 2011-12-31 Filed 2012-02-15
10-Q 2011-07-31 Filed 2011-09-19
10-Q 2011-04-30 Filed 2011-06-20
10-Q 2011-01-31 Filed 2011-03-17
10-K 2010-10-31 Filed 2011-02-15
10-Q 2010-07-30 Filed 2010-09-17
10-Q 2010-04-30 Filed 2010-06-14
10-Q 2010-01-31 Filed 2010-03-22
10-K 2009-10-31 Filed 2010-02-12
8-K 2020-03-13
8-K 2020-03-09
8-K 2018-04-19

Advanced Biomedical Technologies Financials

ABMT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-07-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Cash654349443238555754744710259381823977361071913167171211
Accounts Receivable
Inventory3001436
PP&E64148142462137132128128118113488129511513505485494483473466465477483514511488521550551540
Assets178235208214204187188206198192218210312194166146143116101991208985105129131142190199218
Accounts Payable
Long-Term Debt
Liabilities1,5402,1032,2062,4402,6042,7402,9073,3503,4283,6713,9564,0914,4334,5154,6274,1564,3684,4164,4634,5534,6094,8455,0805,5745,7655,6215,7616,2706,4806,589
Stockholders' Equity-1,362-1,868-1,999-2,226-2,400-2,553-2,718-3,144-3,230-3,479-3,739-3,881-4,121-4,321-4,461-4,010-4,225-4,300-4,362-4,454-4,489-4,756-4,995-5,469-5,636-5,490-5,619-6,080-6,281-6,370
Income Statement ($'000)2011-07-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Revenue
Cost of Revenue
Gross Profit
R&D13314519351014208231297351722-17141381316813171648
SG&A158111-11241098810113315013216113414610712881125799070100749812211812114812771
Tax00000000000000
Net Income-189-160-191-208-175-139-157-199-185-212-232-223-229-211-211-191-215-174-145-154-183-170-184-223-209-216-253-236-213
Cash Flow ($'000)2011-07-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Cash Operating-157-151-131-168-197-198-169-221-225-186-190-18273-159-103-134-57-141-226-228-178-195-200-228-122
Cash Investing-4-2-2-0-1-7-1-0-16-16-000-1-1-00100-0-4-34-12-25-4-5
Cash Financing127201153138139181201195205210280142170164-6714610113386115224243207210235228126